Novel approach for CES1 genotyping: integrating single nucleotide variants and structural variation

Area of Science:

• Genetics
• Molecular Biology
• Pharmacogenomics

Background:

• The CES1 gene plays a crucial role in drug metabolism.
• Variations in CES1 gene copies, including CES1A1, CES1A2, and the pseudogene CES1P1, can impact drug efficacy and safety.
• Accurate genotyping is essential for understanding these genetic influences.

Purpose of the Study:

• To develop and validate a specific genotyping procedure for CES1A1 and CES1A2.
• To enable the accurate determination of copy numbers for CES1A1, CES1A2, and CES1P1.
• To facilitate the sequencing of single nucleotide variants within CES1A1 and CES1A2.

Main Methods:

• Real-time PCR was employed to quantify the copy numbers of CES1A1, CES1A2, and CES1P1.
• Long-range PCR followed by secondary PCR was utilized for selective amplification.
• Sequencing of single nucleotide variants in CES1A1 and CES1A2 was performed on amplified products.

Main Results:

• A two-step genotyping procedure was successfully developed.
• The first step accurately determined copy numbers, indicating the presence of CES1A2.
• The second step selectively amplified CES1A1 and CES1A2 for sequencing, demonstrating high specificity.
• Analysis of 501 DNA samples confirmed the procedure's effectiveness.

Conclusions:

• The developed procedure provides specific genotyping for CES1A1 and CES1A2.
• This method allows for the determination of gene copy numbers and sequence variants.
• The findings support the potential for personalized drug treatments based on CES1 gene variations.